Art

J-GLOBAL ID：201902216872484282   Reference number：19S1475737

β-galactosidase treatment is a common first-stage modification of the three major subtypes of Gc protein to GcMAF

Author (13)： Uto, Yoshihiro (Department of Life System, Institute of Technology and Science, University of Tokushima) ,  Yamamoto, Syota (Department of Life System, Institute of Technology and Science, University of Tokushima) ,  Mukai, Hirotaka (Department of Life System, Institute of Technology and Science, University of Tokushima) ,  Ishiyama, Noriko (Department of Life System, Institute of Technology and Science, University of Tokushima) ,  Takeuchi, Ryota (Department of Life System, Institute of Technology and Science, University of Tokushima) ,  Takeuchi, Ryota (Morita Pharmaceutical Ind. Ltd.) ,  Hori, Hitoshi (Department of Life System, Institute of Technology and Science, University of Tokushima) ,  Nakagawa, Yoshinori (Morita Pharmaceutical Ind. Ltd.) ,  Hirota, Keiji (Faculty of Pharmaceutical Sciences, Tokyo University of Science) ,  Hirota, Keiji (Center for Drug Delivery Research, Tokyo University of Science) ,  Terada, Hiroshi (Faculty of Pharmaceutical Sciences, Tokyo University of Science) ,  Terada, Hiroshi (Center for Drug Delivery Research, Tokyo University of Science) ,  Onizuka, Shinya (Nagasaki Municipal Hospital)
Material： Anticancer Research
Volume： 32  Issue： 6  Page： 2359-2364  Publication year： 2012 
JST Material Number： SCOPUS  ISSN： 0250-7005  CODEN： ANTRD 
Country of issue： Greece (GRC)  Language： English (EN)

Terms in the title (2)： IS ,  GC